Alix Marzelli is noted as a new health care counsel in the firm’s Washington, D.C. office.
In the News
January 31, 2022
Bloomberg Law | Wake Up Call
Related News & Insights
-
Health Care Week in Review April 25, 2025Health Care Week in Review | Senate HELP Committee Chair Cassidy Calls for 340B Reforms; House Republicans Launch American-Made Medicines CaucusThis week, Senator Bill Cassidy released findings from an investigation into the 340B drug pricing program, and a group of House Republicans launched the American-Made Medicines Caucus in support of the domestic production of pharmaceuticals.
-
Health Care Week in Review April 18, 2025Health Care Week in Review | President Trump Announces Actions to Lower Drug Prices; Trump Administration Initiates Section 232 Investigation on PharmaceuticalsThis week, President Trump signed an executive order directing HHS to take steps to lower prescription drug prices, and the U.S. Department of Commerce announced an investigation into the impact of pharmaceuticals and pharmaceutical ingredients on U.S. national security.
-
Health Care Week in Review April 11, 2025Health Care Week in Review | House and Senate Agree to Budget Resolution; CMS Releases Inpatient and Post-Acute Payment Proposed Rules
This week, the House and Senate both agreed to a joint budget resolution, advancing to the next step of the reconciliation process, and CMS released its proposed rules for FY 2026 inpatient and post-acute care payments.
-
Speaking Engagement April 10, 20252025 Health Policy AcademyMike Park will speak at this annual event hosted by the Alliance for Health Policy, moderating a panel titled “Introduction to the Regulatory Process.”
-
Speaking Engagement April 9-10, 2025Population Health Management SummitElinor Hiller will speak on the panel “Medicare Advantage and PHM: Congressional and Administrative Priorities and Considerations” at this two-day conference hosted by the AHCA/NCAL.
-
Webinar April 8, 2025Deregulation Through Repeal or Nonenforcement of Federal Regulations: What Are the Legal Limits? Implications of the DOGE Executive OrderJoin Dan Jarcho and CJ Frisina as they discuss the legal limitations on agency deregulation through repeal or non-enforcement of federal regulations.
-
Healthy Byte April 7, 2025Healthy Byte | How to Minimize Government Enforcement Risk When Deploying AI in Health CareThis Healthy Byte explores how health care companies can minimize regulatory and enforcement risks of deploying AI solutions.
-
Health Care Week in Review April 4, 2025Health Care Week in Review | Oz Confirmed as CMS Administrator; CMS finalizes CY 2026 MA/Part D Final Rule
This week, Mehmet Oz was confirmed by the Senate as Administrator of CMS and CMS finalized the Contract Year 2026 Medicare Advantage and Medicare Part D rule.
-
Webinar April 3, 2025Navigating AI in Health Care and Life Sciences – Due Diligence and Contracting EssentialsJoin Sean Sullivan, Jennifer Pike, and Dorian Simmons for an exclusive webinar designed for health care and life sciences professionals considering using vendors who deploy artificial intelligence.
-
Health Care Week in Review March 28, 2025Health Care Week in Review | HHS Announces Significant Workforce Reductions and Reorganization; FDA and NIH Nominees are Confirmed
This week, HHS announced plans for an additional reduction in 10,000 full-time employees and consolidation of departmental divisions, and the nominees to head the FDA and the NIH were confirmed by the Senate.
Media Contact
- Health Care
- FDA: Drug & Device
- Life Sciences
- Health Care Legislative & Public Policy
- Chemical & Product Regulation
- Health Care Litigation
- Corporate Compliance Programs
- Toxic Substances Control Act (TSCA)
- Biotechnology, Pharmaceutical & Life Sciences Patent Litigation
- Food, Beverage & Agribusiness
- FDA Compliance & Enforcement